{
    "medicine_id": "d6140c7aea6270eaa8e59ed45a9e1c728dd36c3a",
    "platform_id": "5517",
    "metadata": {
        "name": "Ziagen 20 mg ml oral solution",
        "composition": "Each ml of oral solution contains 20 mg of abacavir as sulfate",
        "clinical_particulars": {
            "therapeutic_indications": "Ziagen is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus HIV infection in adults adolescents and children see sections 4 4 and 5 1 The demonstration of the benefit of Ziagen is mainly based on results of studies performed in treatment na\u00efve adult patients on combination therapy with a twice daily regimen see section 5 1 Before initiating treatment with abacavir screening for carriage of the HLA B 5701 allele should be performed in any HIV infected patient irrespective of racial origin see section 4 4 Abacavir should not be used in patients known to carry the HLA B 5701 allele",
            "contraindications": {
                "disease": "Hypersensitivity to abacavir or to any of the excipients listed in section 6 1 See sections 4 4 and 4 8",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Sorbitol 70% (E420);Saccharin sodium;Sodium citrate;Citric acid anhydrous;Methyl parahydroxybenzoate (E218);Propyl parahydroxybenzoate (E216);Propylene glycol (E1520);Maltodextrin;Lactic acid;Glyceryl triacetate;Artificial strawberry and banana flavours;Purified water;Sodium hydroxide and/or hydrochloric acid for pH adjustment.",
                "incompatibilities": "Not applicable"
            }
        },
        "revision_date": "2021-01-14"
    }
}